BioNTech and Israel's Weizmann Institute of Science have signed a Memorandum of Understanding (MoU) to partner on research on cancer, infectious disease and neurodegenerative diseases at BioNTech’s new mRNA Excellence Center. BioNTech will also create...
Spark Therapeutics, a Roche company, has officially started work on its US$575m gene therapy innovation center in West Philadelphia. The center is expected to be completed by 2026.
